User profiles for G. Contreras

Genaro Andres Contreras

- Verified email at msu.edu - Cited by 2934

German andres contreras

- Verified email at uth.tmc.edu - Cited by 1063

Metabolic factors affecting the inflammatory response of periparturient dairy cows

LM Sordillo, GA Contreras, SL Aitken - Animal health research …, 2009 - cambridge.org
Dairy cattle are susceptible to increased incidence and severity of disease during the
periparturient period. Increased health disorders have been associated with alterations in bovine …

[HTML][HTML] Management of multidrug-resistant enterococcal infections

CA Arias, GA Contreras, BE Murray - Clinical microbiology and infection, 2010 - Elsevier
… faecium with MICs of ampicillin of ≤64 mg/L may respond to high-dose ampicillin therapy
(18–30 g per day plus one of the recommended aminoglycosides) because sufficient plasma …

Mastitis: comparative etiology and epidemiology

GA Contreras, JM Rodríguez - Journal of mammary gland biology and …, 2011 - Springer
Mastitis is broadly defined as the inflammation of the mammary gland; however, the concept
of mastitis is customized to address its social and clinical impact in the case of humans and …

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

GB Appel, G Contreras, MA Dooley… - Journal of the …, 2009 - journals.lww.com
… patients in the MMF group as 2.6 g/d; median average dosage was … g/d; Asian 2.6 g/d; black
2.4 g/d; and other 2.8 g/d). The corresponding mean ± SD average dosage was 2.47 ± 0.58 g

Intensive blood-pressure control in hypertensive chronic kidney disease

…, J Charleston, G Contreras… - … England Journal of …, 2010 - Mass Medical Soc
Background In observational studies, the relationship between blood pressure and end-stage
renal disease (ESRD) is direct and progressive. The burden of hypertension-related …

[HTML][HTML] Sequential therapies for proliferative lupus nephritis

G Contreras, V Pardo, B Leclercq, O Lenz… - … England Journal of …, 2004 - Mass Medical Soc
… Organization class III, 46 in class IV, and 1 in class Vb) received induction therapy consisting
of a maximum of seven monthly boluses of intravenous cyclophosphamide (0.5 to 1.0 g per …

Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis

…, F Eitner, GB Appel, G Contreras… - … England Journal of …, 2011 - Mass Medical Soc
… We carried out a 36-month, randomized, double-blind, double-dummy, phase 3 study
comparing oral mycophenolate mofetil (2 g per day) and oral azathioprine (2 mg per kilogram of …

[HTML][HTML] Two-year, randomized, controlled trial of belimumab in lupus nephritis

…, A Malvar, YKO Teng, G Contreras… - … England Journal of …, 2020 - Mass Medical Soc
… of mycophenolate mofetil at a dose of 1 to 3 g per day until the end of the trial, although
after 6 months, the dose could be reduced to 1 g per day. At the investigator’s discretion, high-…

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study

D Isenberg, GB Appel, G Contreras, MA Dooley… - …, 2010 - academic.oup.com
g/day in Week 1 and 2 g/day in Week 2 to a target dose of 3 g/day in Week 3, or IVC (monthly
pulses of 0.5–1.0 g… intolerance of MMF doses of 3 g/day, but could tolerate 2–2.5 g/day, or if …

Power prediction for Intel XScale® processors using performance monitoring unit events

G Contreras, M Martonosi - … of the 2005 international symposium on Low …, 2005 - dl.acm.org
This paper demonstrates a first-order, linear power estimation model ha uses performance
counters to estimate run-time CPU and memory power consumption of the Intel PXA255 …